Sms Pharmaceuticals Limited (SMSPHARMA)
ISIN: - Industry: Drug Manufacturers—General Sector: Healthcare Website
87.7
3.35(3.97%)

SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, erectile dysfunction, antiemetic, antiepileptic, antipsychotic, anti-hypertensive, anti-anginal, anti-viral, urinary antispasmodic, and anti-retroviral APIs. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

87.8

TODAY'S LOW

84.85

52 WEEK HIGH

198.8

52 WEEK LOW

81.1

Major Holders

% of Shares Held by
All Insider

71.86%

% of Shares Held by
Institutions

0.00%

% of Float Held by
Institutions

0.00%

Number of Institutions
Holding Shares

0

Company Overview

MARKET CAP

742.82 Cr.

ETERPRISE VALUE

955.43 Cr.

NO. OF SHARES

8.46 Cr.

BOOK VALUE

53.687

DIV. YIELD

0.3%

DEBT

246.93 Cr.

GROSS PROFIT

185.44 Cr.

CASH

30.08 Cr.

REVENUE

634.83 Cr.

REVENUE/SHARE

75.006

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Investments000-8.02 Cr.
Change To Liabilities20.94 Cr.-3.75 Cr.8.98 Cr.-28.04 Cr.
Total cashflows from Investing Activities-151.59 Cr.-42.56 Cr.-34.67 Cr.-16.57 Cr.
Net Borrowings98.16 Cr.8.45 Cr.-2.46 Cr.-3.02 Cr.
Total Cash from Financing Activities92.01 Cr.-2.40 Cr.-12.91 Cr.-14.89 Cr.
Other Liabilities32.13 Cr.-8.76 Cr.-3.57 Cr.-2.31 Cr.
Total Assets0000
Net Income62.52 Cr.31.57 Cr.40.04 Cr.31.74 Cr.
Change in Cash30.87 Cr.-5.25 Cr.2.16 Cr.34.55 Lakhs
Effect of Exchange Rate0000
Total Cash from Operating Activities90.45 Cr.39.71 Cr.49.75 Cr.31.81 Cr.
Depreciation22.18 Cr.21.95 Cr.19.16 Cr.19.76 Cr.
Other Cashflows from Investing Activities2.36 Lakhs3.67 Lakhs7.19 Lakhs11 k
Dividends Paid0-4.23 Cr.-2.11 Cr.-2.03 Cr.
Change to Inventory-8.58 Cr.7.19 Cr.-28.92 Cr.-14.95 Cr.
Change to Account Receivables-56.98 Cr.-22.74 Cr.-1.97 Cr.-2.86 Cr.
Other Cashflows from Financing Activities-6.14 Cr.-6.62 Cr.-8.33 Cr.-9.83 Cr.
Change to Net Income17.96 Cr.13.60 Cr.16.35 Cr.28.62 Cr.
Capital Expenditures-151.74 Cr.-42.73 Cr.-34.83 Cr.-8.55 Cr.

Financials

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax92.68 Cr.49.64 Cr.60.94 Cr.51.64 Cr.
Minority InterestNoneNoneNoneNone
Net Income101.43 Cr.60.97 Cr.72.95 Cr.74.76 Cr.
Selling General Administrative41.49 Cr.41.01 Cr.37.24 Cr.34.25 Cr.
Gross Profit185.44 Cr.133.85 Cr.138.89 Cr.139.22 Cr.
Ebit101.43 Cr.60.97 Cr.72.95 Cr.74.76 Cr.
Operating Income101.43 Cr.60.97 Cr.72.95 Cr.74.76 Cr.
Other Operating Expenses20.23 Cr.9.80 Cr.9.41 Cr.10.30 Cr.
Interest Expense-10.25 Cr.-11.19 Cr.-11.41 Cr.-14.77 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense30.15 Cr.18.06 Cr.20.90 Cr.19.89 Cr.
Total Revenue565.14 Cr.414.30 Cr.466.74 Cr.463.91 Cr.
Total Operating Expenses463.71 Cr.353.32 Cr.393.79 Cr.389.14 Cr.
Cost of Revenue379.70 Cr.280.44 Cr.327.85 Cr.324.68 Cr.
Total Other Income Expense Net-8.74 Cr.-11.33 Cr.-12 Cr.-23.11 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.62.52 Cr.31.57 Cr.40.04 Cr.31.74 Cr.
Net Income Applicable to Common Shares62.52 Cr.31.57 Cr.40.04 Cr.31.74 Cr.

Balance Sheet

ParticularsMar 2021Mar 2020Mar 2019Mar 2018
Intangible Assets1.60 Cr.83.26 Lakhs1.14 Cr.36.27 Lakhs
Capital Surplus69.81 Cr.69.81 Cr.69.81 Cr.69.81 Cr.
Total Liabilities401.68 Cr.259.67 Cr.236.89 Cr.218.03 Cr.
Stock Holder Equity410.52 Cr.348.23 Cr.321.91 Cr.284.48 Cr.
Minority Interest0000
Other Liabilities21.61 Cr.14.13 Cr.10.81 Cr.5.32 Cr.
Total Assets812.21 Cr.607.91 Cr.558.81 Cr.502.52 Cr.
Common Stock8.46 Cr.8.46 Cr.8.46 Cr.8.46 Cr.
Retained Earnings330.69 Cr.268.40 Cr.242.08 Cr.204.65 Cr.
Other Liabilities55.69 Cr.41.47 Cr.32.13 Cr.25.18 Cr.
Good Will0000
Treasury Stock1.55 Cr.1.55 Cr.1.55 Cr.1.55 Cr.
Other Assets11.47 Cr.40.71 Cr.24.67 Cr.18.19 Cr.
Cash40.42 Cr.9.54 Cr.14.79 Cr.12.63 Cr.
Current Liabilities194.09 Cr.145.20 Cr.142.54 Cr.121.45 Cr.
Long Term Asset Charges0000
Short Long Term Debt31.82 Cr.22.91 Cr.10.75 Cr.16.33 Cr.
Other Stockholder Equity1.55 Cr.1.55 Cr.1.55 Cr.1.55 Cr.
Property Plant Equipment462.50 Cr.321.77 Cr.298.40 Cr.287.09 Cr.
Total Cur. Assets309.32 Cr.218.78 Cr.207.59 Cr.168.48 Cr.
Long Term Investments27.30 Cr.25.81 Cr.26.99 Cr.28.38 Cr.
Net Tangible Assets408.92 Cr.347.40 Cr.320.76 Cr.284.12 Cr.
Short Term Investments0000
Net Receivables122.64 Cr.67.85 Cr.51.70 Cr.45.59 Cr.
Long Term Debt147.83 Cr.68.22 Cr.62.21 Cr.71.39 Cr.
Inventory137.78 Cr.129.20 Cr.136.39 Cr.107.47 Cr.
Accounts Payable54.95 Cr.39.55 Cr.42.17 Cr.32.69 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account